Rhumbline Advisers Enovis Corp Transaction History

Rhumbline Advisers

$109 Billion
Q4 2024

A detailed history of Rhumbline Advisers transactions in Enovis Corp stock. As of the latest transaction made, Rhumbline Advisers holds 152,628 shares of ENOV stock, worth $6.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

152,628

Previous 150,690 1.29%

Holding current value

$6.67 Million

Previous $6.49 Million 3.33%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$38.5 - $49.33 $74,613 - $95,601	1,938 Added 1.29%	152,628 $6.7 Million
Q3 2024 Nov 12, 2024	BUY	$40.57 - $48.1 $422,293 - $500,672	10,409 Added 7.42%	150,690 $6.49 Million
Q2 2024 Aug 01, 2024	SELL	$44.56 - $62.43 $84,262 - $118,055	-1,891 Reduced 1.33%	140,281 $6.34 Million
Q1 2024 May 09, 2024	SELL	$55.44 - $63.8 $376,714 - $433,521	-6,795 Reduced 4.56%	142,172 $8.88 Million
Q4 2023 Feb 08, 2024	SELL	$43.67 - $57.07 $177,212 - $231,590	-4,058 Reduced 2.65%	148,967 $8.35 Million
Q3 2023 Nov 09, 2023	SELL	$51.65 - $65.54 $156,086 - $198,061	-3,022 Reduced 1.94%	153,025 $8.07 Million
Q2 2023 Aug 08, 2023	BUY	$52.7 - $64.12 $497,909 - $605,805	9,448 Added 6.44%	156,047 $10 Million
Q1 2023 May 11, 2023	SELL	$49.5 - $65.92 $80,536 - $107,251	-1,627 Reduced 1.1%	146,599 $7.84 Million
Q4 2022 Feb 14, 2023	BUY	$44.83 - $57.43 $341,963 - $438,076	7,628 Added 5.43%	148,226 $7.93 Million
Q3 2022 Nov 10, 2022	BUY	$46.07 - $60.1 $205,057 - $267,505	4,451 Added 3.27%	140,598 $6.48 Million
Q2 2022 Aug 11, 2022	BUY	$55.0 - $70.47 $7.49 Million - $9.59 Million	136,147 New	136,147 $7.49 Million

Others Institutions Holding ENOV

# of Institutions

307

Shares Held

61M

Call Options Held

1.8M

Put Options Held

575K

View Full List

About Enovis CORP

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.37B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

More about ENOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Enovis Corp Transaction History